MEDICLIN Aktiengesellschaft (ETR:MED)
Germany · Delayed Price · Currency is EUR 4.360
+0.260 (6.34%)
Aug 4, 2026, 5:35 PM CET
ETR:MED Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 29.38 | 25.9 | 24.91 | -10.72 | 9.72 | 1.49 |
Depreciation & Amortization | 61.21 | 60.22 | 50.28 | 86.01 | 71.4 | 73.66 |
Other Adjustments | 5.36 | 24.28 | 22.76 | 19.39 | 2.48 | 3.16 |
Change in Receivables | -7.97 | -7.62 | -15.42 | -20.99 | -27.36 | -25.72 |
Changes in Accounts Payable | 4.22 | 2.74 | -0.95 | -2.6 | -18.57 | 32.51 |
Changes in Accrued Expenses | 0.53 | -3.76 | -2.77 | 1.31 | -1.12 | -1.62 |
Changes in Income Taxes Payable | -13.43 | -2.28 | -3.02 | 2.83 | -3.24 | -2.37 |
Changes in Other Operating Activities | 0.3 | -0.44 | 0.76 | 0.01 | -0.38 | -0.77 |
Operating Cash Flow | 97.94 | 102.44 | 80.57 | 78 | 34.64 | 81.97 |
Operating Cash Flow Growth | 4.92% | 27.15% | 3.29% | 125.18% | -57.74% | -30.94% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -41.98 | -48.43 | -38.04 | -34.42 | -24.37 | -15.23 |
Sale of Property, Plant & Equipment | 0.94 | 0.31 | 0.97 | 0.47 | 0.67 | 0.29 |
Purchases of Intangible Assets | -4.1 | -3 | -6.65 | -3.16 | -1.65 | -1.78 |
Purchases of Investments | - | -0.1 | -0.01 | -0.04 | -0.04 | -0.04 |
Proceeds from Business Divestments | - | 0 | 9.5 | 8.65 | 0 | - |
Other Investing Activities | 24.44 | 14.08 | 19.1 | 18.99 | 19.14 | 9.66 |
Investing Cash Flow | -20.74 | -37.14 | -15.13 | -9.51 | -6.24 | -7.09 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | -77.68 | -77.11 | -50.38 | -23.65 | -46.1 | -46.97 |
Net Long-Term Debt Issued (Repaid) | -77.68 | -77.11 | -50.38 | -23.65 | -46.1 | -46.97 |
Common Dividends Paid | - | -1.9 | 0 | - | - | - |
Other Financing Activities | -18.92 | -17.56 | -18.77 | -19.04 | -8.36 | -6.68 |
Financing Cash Flow | -99.07 | -99.97 | -73.16 | -45.48 | -56.17 | -55.26 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 5.45 | -34.67 | -7.73 | 23.01 | -27.77 | 19.62 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 55.96 | 54.01 | 42.52 | 43.58 | 10.27 | 66.74 |
Free Cash Flow Growth | 11.21% | 27.02% | -2.43% | 324.41% | -84.61% | -30.80% |
FCF Margin | 7.11% | 6.72% | - | 5.68% | 1.42% | 9.71% |
Free Cash Flow Per Share | 1.18 | 1.14 | 0.90 | 0.92 | 0.22 | 1.40 |
Levered Free Cash Flow | -37.72 | -43.57 | -44.12 | 18.7 | -12.95 | 40.68 |
Unlevered Free Cash Flow | 35.2 | 48.79 | 6.25 | 68.83 | 114.1 | 93.21 |